Cosmo Feilding Mellen
Algemeen Directeur bij Beckley Canopy Therapeutics Ltd.
Profiel
Cosmo Feilding Mellen has founded Beckley Psytech Ltd.
in 1998, where he currently holds the title of Chief Executive Officer & Director.
He is also currently working as Co-Managing-Director & Director at Beckley Canopy Therapeutics Ltd.
Actieve functies van Cosmo Feilding Mellen
| Bedrijven | Functie | Begin |
|---|---|---|
Beckley Canopy Therapeutics Ltd.
 Beckley Canopy Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom. | Algemeen Directeur | - |
Beckley Psytech Ltd.
 Beckley Psytech Ltd. Pharmaceuticals: MajorHealth Technology Beckley Psytech Ltd. operates as a psychedelic medicine company. It engages in helping patients suffering from neurological and mental health disorders by developing psychedelic compounds. The company was founded by Lady Amanda Feilding and Cosmo Feilding Mellen in 1998 and is headquartered in the United Kingdom. | Oprichter | 01-01-1998 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Beckley Canopy Therapeutics Ltd.
Beckley Canopy Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom. | Commercial Services |
Beckley Psytech Ltd.
Beckley Psytech Ltd. Pharmaceuticals: MajorHealth Technology Beckley Psytech Ltd. operates as a psychedelic medicine company. It engages in helping patients suffering from neurological and mental health disorders by developing psychedelic compounds. The company was founded by Lady Amanda Feilding and Cosmo Feilding Mellen in 1998 and is headquartered in the United Kingdom. | Health Technology |
